European Council of the Paint, Printing Ink and Artists' Colours Industry, 19 Feb 2020
CEPE requests simplifying the review program to tackle the most important problems first. They argue that endocrine disruption requirements should not expand to co-formulants. This would protect the supply of preservatives and reduce administrative burden.
Health advocates lose early protection from substances that interfere with hormones.